Newman J. Michael's most recent trade in Indaptus Therapeutics Inc was a trade of 52,204 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director | Grant, award, or other acquisition of securities at price $ 2.03 per share. | 22 Dec 2025 | 52,204 | 101,074 | - | 2.0 | 105,974 | Common Stock |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Newman J. Michael | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 43,250 | 43,250 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 43,250 | 43,250 | - | - | Stock Option (Right to Buy) | |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 31 Jan 2022 | 14,130 | 1,368,356 | - | 5.0 | 70,692 | Common Stock |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 31 Jan 2022 | 5,870 | 1,382,486 | - | 5.0 | 29,351 | Common Stock |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 43,350 | 43,350 | - | - | Stock Option (right to buy) | |
| Indaptus Therapeutics Inc | Michael J. Newman | Director, CSO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 290,000 | 290,000 | - | - | Stock Option (right to buy) |